UPDATE 2-J&J says offered $2.1 bln for LifeScan diabetes unit

16 Mar 2018

March 16 (Reuters) – Johnson & Johnson has been
offered about $2.1 billion for its LifeScan Inc unit, which
makes blood glucose monitoring products, by private investment
firm Platinum Equity, the healthcare company said on Friday.

Read full article at Reuters